People · Operator
Named in public records as an officer, director or promoter · active 2018–2019 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| LSK BioPartners, Inc. | — | Pharmaceuticals | Series B | $40.0M | $680.1M | 2018 |
Ha Young Kim at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Ha Young Kim on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Alex Kim | 1 | 2 |
| Sung Chul Kim | 1 | 1 |
| Anton Gueth | 1 | 1 |
| Soo Whan Choi | 1 | 1 |
| Weili Cheng | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.